Longboard Pharmaceuticals Inc
(LBPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LBPH | AZN | AMGN | GILD | VRTX |
| Company | Longboard Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 59.99 | 187.50 | 339.47 | 141.05 | 466.79 |
| High | 60.03 | 191.43 | 345.31 | 143.80 | 473.19 |
| Low | 59.98 | 187.50 | 339.41 | 140.01 | 464.01 |
| Latest | 59.98 | 190.56 | 345.31 | 142.77 | 471.60 |
| Change | +0.02 | +97.79 | +3.43 | +0.82 | +1.70 |
| % Change | +0.03% | +105.41% | +1.00% | +0.58% | +0.36% |
| Volume | 655,700 | 800,880 | 355,924 | 1,442,283 | 155,987 |
| 20-Day Average Volume | 866,510 | 9,302,292 | 2,685,914 | 7,586,585 | 1,497,228 |
| Previous Close | 59.96 | 92.77 | 341.88 | 141.95 | 469.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.78 | 98.35 | 336.31 | 129.18 | 463.18 |
| 20-Day Raw Stochastic | 95.87% | 99.11% | 72.73% | 96.62% | 70.40% |
| 20-Day Relative Strength | 76.13 | 91.41 | 57.24 | 70.20 | 56.36 |
| Weighted Alpha | +188.68 | +68.67 | +21.40 | +52.06 | +5.58 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 80% Buy | 64% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.35% since 11/21/24 | +102.19% since 01/26/26 | -1.71% since 01/26/26 | +3.71% since 01/26/26 | -1.39% since 01/26/26 |
| Low | 59.77 on 11/22/24 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 137.54 on 01/27/26 | 464.01 on 02/02/26 |
| High | 60.03 on 11/29/24 | 191.43 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | +0.69% since 10/29/24 | +108.06% since 01/02/26 | +4.90% since 01/02/26 | +17.51% since 01/02/26 | +4.00% since 01/02/26 |
| Low | 58.82 on 11/04/24 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 60.03 on 11/29/24 | 191.43 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +68.77% since 08/29/24 | +131.21% since 10/31/25 | +15.17% since 10/31/25 | +19.28% since 10/31/25 | +10.49% since 10/31/25 |
| Low | 27.35 on 09/17/24 | 80.48 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 403.16 on 11/04/25 |
| High | 60.03 on 11/29/24 | 191.43 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +229.38% since 05/29/24 | +157.63% since 08/01/25 | +15.77% since 08/01/25 | +26.25% since 08/01/25 | +1.75% since 08/01/25 |
| Low | 15.64 on 06/10/24 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 60.03 on 11/29/24 | 191.43 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,341,979 | 287,755,456 | 184,095,904 | 176,114,528 | 119,222,552 |
| Shares Outstanding, K | 39,046 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -54,420,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -24,540,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.07 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/07/24 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/11/25 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.26 | 15.68 | 17.04 | 31.07 |